Cart
sales@molnova.com
LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))
CAS No. ——
LMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))( —— )
Catalog No. M19315 CAS No. ——
LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 298 | Get Quote |
|
| 10MG | 470 | Get Quote |
|
| 25MG | 658 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLMPTP INHIBITOR 1 hydrochloride (1908414-82-3(free base))
-
NoteResearch use only, not for human use.
-
Brief DescriptionLMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
-
DescriptionLMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP), with an IC50 of 0.8 μM LMPTP-A.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetIGF-1R
-
RecptorLMPTP-A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight481.07
-
Molecular FormulaC28H37ClN4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCl.Cl.CCN(CC)C(=O)c1ccc(cc1)c3nc2ccccc2c(c3)NCCCN4CCCCC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Stanford SM1, et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol. 2017 Jun;13(6):624-632.
molnova catalog
related products
-
NVP-ADW742
NVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 μM.
-
GSK1904529A
GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM.
-
Ganitumab
Ganitumab (AMG 479) is a highly potent monoclonal antibody targeting the type 1 insulin-like growth factor receptor (IGF1R). Recognized for binding IGF1R at low concentrations with a KD value of 0.22 nM, Ganitumab inhibits IGF1R interactions with IGF1 and IGF2 in mice, making it useful for cancer research.
